Trial intelligence / Profile preview

Unacylated ghrelin infusion during hyperinsulinemic clamp in adults with type 2 diabetes

NL-OMON36378Not yet recruiting

Sponsor
Erasmus MC
Start
Dec 2010
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Trial of unacylated ghrelin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Erasmus MC. Primary endpoint: Insulin levels. Planned start Dec 2010; status: not yet recruiting.

02

Drugs

unacylated ghrelin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NL-OMON36378.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON36378.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call